Paying users zone. Data is hidden behind: .
Get 1-month access to Regeneron Pharmaceuticals Inc. for $13.99, or
get full access to the entire website for at least 3 months from $49.99.
This is a one-time payment. There is no automatic renewal.
Enterprise Value (EV)
Current Enterprise Value (EV)
Regeneron Pharmaceuticals Inc., current enterprise value calculation
|Current share price (P)|
|No. shares of common stock outstanding|
|US$ in thousands|
|Common equity (market value)1|
|Add: Preferred Stock, $.01 par value; none issued and outstanding (per books)|
|Add: Finance lease liabilities, current portion (per books)|
|Add: Long-term debt (per books)|
|Add: Finance lease liabilities, excluding current portion (per books)|
|Total equity and debt|
|Less: Cash and cash equivalents|
|Less: Marketable securities|
|Enterprise value (EV)|
Based on: 10-K (filing date: 2021-02-08).
1 Common equity (market value) = Share price × No. shares of common stock outstanding
Historical Enterprise Value (EV)
Regeneron Pharmaceuticals Inc., EV calculation
1 Data adjusted for splits and stock dividends.
2 Closing price as at the filing date of Regeneron Pharmaceuticals Inc.’s Annual Report.
3 2020 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
|EV||Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments.||Regeneron Pharmaceuticals Inc.’s EV decreased from 2018 to 2019 but then increased from 2019 to 2020 exceeding 2018 level.|